1. Home
  2. G vs BIO Comparison

G vs BIO Comparison

Compare G & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genpact Limited

G

Genpact Limited

HOLD

Current Price

$38.96

Market Cap

7.2B

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$300.48

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
G
BIO
Founded
1997
1952
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.0B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
G
BIO
Price
$38.96
$300.48
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$50.33
$358.50
AVG Volume (30 Days)
1.4M
234.7K
Earning Date
02-05-2026
02-12-2026
Dividend Yield
1.54%
N/A
EPS Growth
N/A
N/A
EPS
3.10
N/A
Revenue
$5,009,342,000.00
$2,557,500,000.00
Revenue This Year
$8.47
$1.50
Revenue Next Year
$6.96
$2.23
P/E Ratio
$14.23
N/A
Revenue Growth
7.39
N/A
52 Week Low
$37.49
$211.43
52 Week High
$56.76
$358.40

Technical Indicators

Market Signals
Indicator
G
BIO
Relative Strength Index (RSI) 20.78 40.62
Support Level $43.87 $289.11
Resistance Level $44.77 $302.59
Average True Range (ATR) 1.24 9.53
MACD -0.58 -1.67
Stochastic Oscillator 1.74 27.47

Price Performance

Historical Comparison
G
BIO

About G Genpact Limited

Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: